Change in number of shares and votes in Episurf Medical

Episurf Medical AB (NASDAQ: EPIS B): On behalf of shareholders in Episurf Medical AB, conversion of class A-shares to B-shares were carried out during August in accordance with the Articles of Association. Through the conversions, the number of A-shares has decreased by 6,000, and the number of B-shares has increased by the same amount.

The total number of shares amounts to 267,065,447, of which 473,357 are A-shares and 266,592,090 are B-shares. The total number of votes after the conversions amounts to 268,012,161.

For more  information, please contact:

Veronica Wallin, CFO, Episurf Medical
Tel:+46 (0) 700 37 48 95
Email: veronica.wallin@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

This information is information that Episurf Medical AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 11:00 CEST on August 31, 2023. 

Tags: